New Key Statistics Module, Z-Score and F-Score
NAS:REGN Key Ratios
| Market Cap $ M | 98,072.25 |
| Enterprise Value $ M | 90,806.25 |
| P/E(ttm) | 25.73 |
| PE Ratio without NRI | 22.29 |
| Forward PE Ratio | 19.94 |
| Price/Book | 3.77 |
| Price/Sales | 7.76 |
| Price/Free Cash Flow | 27.72 |
| Price/Owner Earnings | 36.96 |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 13,117.00 |
| EPS (TTM) $ | 34.75 |
| Beneish M-Score | -2.51 |
| 10-y EBITDA Growth Rate % | 24.90 |
| 5-y EBITDA Growth Rate % | 17.70 |
| y-y EBITDA Growth Rate % | -10.90 |
| EV-to-EBIT | 21.25 |
| EV-to-EBITDA | 19.35 |
| PEG | 1.26 |
| Shares Outstanding M | 109.76 |
| Net Margin (%) | 30.14 |
| Operating Margin % | 32.27 |
| Pre-tax Margin (%) | 32.01 |
| Quick Ratio | 4.94 |
| Current Ratio | 5.69 |
| ROA % (ttm) | 12.74 |
| ROE % (ttm) | 16.33 |
| ROIC % (ttm) | 21.07 |
| Dividend Yield % | -- |
| Altman Z-Score | 10.91 |
| Piotroski F-Score | 6.00 |
| Positive ROA | Y |
| Positive CFROA | Y |
| Higher ROA y-y | N |
| Cash flow > Earnings | Y |
| Lower Leverage y-y | Y |
| Higher Current Ratio y-y | Y |
| Less Shares Outstanding y-y | Y |
| Gross Margin Increase y-y | N |
| Higher Asset Turnover y-y | N |
REGN Number of Guru Trades
REGN Volume of Guru Trades
Gurus Latest Trades with NAS:REGN
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:REGN is held by these investors
Total 6
Regeneron Pharmaceuticals Inc Insider Transactions
No Available Data
News about NAS:REGN
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers